Worldwide prevalence of antibiotic-associated Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis
EY Lee, C Knox, EJ Phillips - JAMA dermatology, 2023 - jamanetwork.com
Importance Antibiotics are an important risk for Stevens-Johnson syndrome and toxic
epidermal necrolysis (SJS/TEN), which are the most severe types of drug hypersensitivity …
epidermal necrolysis (SJS/TEN), which are the most severe types of drug hypersensitivity …
Updates in SJS/TEN: collaboration, innovation, and community
ME Marks, RK Botta, R Abe, TM Beachkofsky… - Frontiers in …, 2023 - frontiersin.org
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) is a predominantly drug-
induced disease, with a mortality rate of 15–20%, that engages the expertise of multiple …
induced disease, with a mortality rate of 15–20%, that engages the expertise of multiple …
A review of the systemic treatment of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
HC Chang, TJ Wang, MH Lin, TJ Chen - Biomedicines, 2022 - mdpi.com
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are uncommon but
life-threatening diseases mostly caused by drugs. Although various systemic …
life-threatening diseases mostly caused by drugs. Although various systemic …
Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome
A Jacobsen, B Olabi, A Langley… - Cochrane Database …, 2022 - cochranelibrary.com
Background Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and
SJS/TEN overlap syndrome are rare, severe cutaneous adverse reactions usually triggered …
SJS/TEN overlap syndrome are rare, severe cutaneous adverse reactions usually triggered …
Lifetime risk, life expectancy, loss-of-life expectancy and lifetime healthcare expenditure for Stevens–Johnson syndrome/toxic epidermal necrolysis in Taiwan: follow …
YM Chiu, HY Chiu - British Journal of Dermatology, 2023 - academic.oup.com
Abstract Background Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis
(TEN) not only cause acute, devastating mucocutaneous reactions but also have long …
(TEN) not only cause acute, devastating mucocutaneous reactions but also have long …
Correlations between histopathologic findings, serum biomarker levels, and clinical outcomes in Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)
D Chuenwipasakul, C Washrawirul, R Panpruk… - Scientific Reports, 2023 - nature.com
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe
dermatological emergencies. The role of cytokines and chemokines in the pathogenesis …
dermatological emergencies. The role of cytokines and chemokines in the pathogenesis …
Patient-Reported Outcome Measures in Food and Drug Allergy
A Anagnostou, C Warren, J Dantzer, AD Galvin… - The Journal of Allergy …, 2024 - Elsevier
A patient-reported outcome is directly reported by the patient without interpretation of the
patient's response by anyone else. It refers to the patient's health (symptoms and feelings) …
patient's response by anyone else. It refers to the patient's health (symptoms and feelings) …
A comprehensive assessment of long-term complications in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
Abstract Introduction: Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN),
and SJS/TEN overlap syndrome are rare severe hypersensitivity reactions that lead to …
and SJS/TEN overlap syndrome are rare severe hypersensitivity reactions that lead to …
Psychotherapeutic interventions for burns patients and the potential use with Stevens-Johnson syndrome and toxic epidermal necrolysis patients: A systematic …
P O'Reilly, P Meskell, B Whelan, C Kennedy… - Plos one, 2022 - journals.plos.org
Background The existing evidence demonstrates that survivors of SJS/TEN have reported
long-lasting psychological effects of their condition. Burns patients experience similar …
long-lasting psychological effects of their condition. Burns patients experience similar …
Toxic Epidermal Necrolysis, A Serious Side Effect of Tenoxicam Use: A Case Report
Tenoxicam, a selective cyclooxygenase (COX)-2 inhibitor, has potent analgesic and anti-
inflammatory effects and is frequently used for out-of-hospital pain control. Even though …
inflammatory effects and is frequently used for out-of-hospital pain control. Even though …